Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824224 | Biochemical Pharmacology | 2009 | 9 Pages |
Abstract
Combination treatment with gefitinib and everolimus might be of value in the treatment of NSCLC cells with high proliferative index.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Silvia La Monica, Maricla Galetti, Roberta R. Alfieri, Andrea Cavazzoni, Andrea Ardizzoni, Marcello Tiseo, Marzia Capelletti, Matteo Goldoni, Sara Tagliaferri, Antonio Mutti, Claudia Fumarola, Mara Bonelli, Daniele Generali, Pier Giorgio Petronini,